12 Oct 2026

Finland has submitted a bill to clarify and harmonise the assessment of hospital and outpatient medicines. Government Proposal HE 243/2026, approved on 8 October, would establish a more comprehensive national hospital-medicine assessment process and provide a limited supply route for treatments falling outside ordinary outpatient reimbursement.

At present, the outpatient and hospital pathways use separate procedures. Hospital-medicine assessments by the Finnish Medicines Agency (Lääkealan turvallisuus- ja kehittämiskeskus, Fimea) inform recommendations by the Council for Choices in Health Care in Finland (Terveydenhuollon palveluvalikoimaneuvosto, Palko), but the process is only partly defined in legislation and some new indications do not receive national assessment.

Under the proposal, Palko would issue a recommendation on a new hospital medicine or indication when the marketing authorisation holder requests one, drawing on Fimea's assessment. Application fees would help finance the expanded work, with amounts determined in subsequent regulations.

The bill would also allow a hospital pharmacy to supply certain outpatient medicines needed for life-threatening or seriously health-threatening conditions when reimbursement cannot be established for the relevant use. An earlier proposed combination-treatment reimbursement exception was removed during preparation after funding was not secured.

The supply provisions are intended to take effect on 1 April 2027 and the principal assessment reforms on 1 January 2028, subject to parliamentary approval. The changes would give developers a more defined national route while retaining separate hospital and outpatient financing systems.

Source: Finnish Government
Link: Hallituksen esitys eduskunnalle lääkkeiden arviointitoiminnan yhtenäistämistä koskevaksi lainsäädännöksi (Government proposal to Parliament for legislation harmonising medicines assessment)
Date: 8 October 2026

Source: Finlex
Link: Hallituksen esitys eduskunnalle lääkkeiden arviointitoiminnan yhtenäistämistä koskevaksi lainsäädännöksi, HE 243/2026 vp (Government Proposal HE 243/2026 on harmonising medicines assessment)
Date: 8 October 2026